Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 2
1996 2
1998 2
1999 4
2000 1
2001 5
2002 3
2003 3
2004 3
2005 1
2006 6
2007 4
2008 1
2009 3
2010 4
2011 3
2012 4
2013 2
2014 2
2015 3
2016 4
2017 1
2018 1
2019 5
2020 3
2021 6
2022 8
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, O'Hagan A, Avadhani A, Siefker-Radtke AO; BLC2001 Study Group. Loriot Y, et al. N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323. N Engl J Med. 2019. PMID: 31340094 Clinical Trial.
Flying Into Depression.
O'Hagan AD, Issartel J, Nevill A, Warrington G. O'Hagan AD, et al. Workplace Health Saf. 2017 Mar;65(3):109-117. doi: 10.1177/2165079916659506. Epub 2016 Sep 28. Workplace Health Saf. 2017. PMID: 27578874
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Siefker-Radtke AO, Necchi A, Park SH, García-Donas J, Huddart RA, Burgess EF, Fleming MT, Rezazadeh Kalebasty A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Akapame S, Santiago-Walker AE, Monga M, O'Hagan A, Loriot Y; BLC2001 Study Group. Siefker-Radtke AO, et al. Lancet Oncol. 2022 Feb;23(2):248-258. doi: 10.1016/S1470-2045(21)00660-4. Epub 2022 Jan 11. Lancet Oncol. 2022. PMID: 35030333 Clinical Trial.
Not what it seems.
McCorry EA, OHagan A, Shah S. McCorry EA, et al. Among authors: ohagan a. Arch Dis Child Educ Pract Ed. 2021 Aug;106(4):237-238. doi: 10.1136/archdischild-2019-318086. Epub 2019 Oct 30. Arch Dis Child Educ Pract Ed. 2021. PMID: 31666289
Predictively consistent prior effective sample sizes.
Neuenschwander B, Weber S, Schmidli H, O'Hagan A. Neuenschwander B, et al. Biometrics. 2020 Jun;76(2):578-587. doi: 10.1111/biom.13252. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32142163
Management of Fibroblast Growth Factor Inhibitor Treatment-emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Siefker-Radtke AO, Necchi A, Park SH, García-Donas J, Huddart RA, Burgess EF, Fleming MT, Rezazadeh Kalebasty A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Qi K, Akapame S, Triantos S, O'Hagan A, Loriot Y. Siefker-Radtke AO, et al. Eur Urol Open Sci. 2023 Feb 16;50:1-9. doi: 10.1016/j.euros.2022.12.019. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 37101768 Free PMC article.
Sterility and Stability Testing of Preservative-free Albuterol.
Gulley SL, Baltzley SM, Junkins AD, Murray TD, Simms SF, Sullivan JE, Al-Ghananeem AM, O'Hagan AR. Gulley SL, et al. J Pediatr Pharmacol Ther. 2019 Jan-Feb;24(1):53-57. doi: 10.5863/1551-6776-24.1.53. J Pediatr Pharmacol Ther. 2019. PMID: 30837815 Free PMC article.
82 results